Helene Peyro-Saint-Paul, MD, Chief Medical Officer of PathoQuest provides an overview of the development, validation and clinical evaluation of the iDTECT™ Blood Test. This test uses a Next-generaton sequencing (NGS) shotgun metagenomics approach and is CE-IVD marked to detect pathogens in blood samples, especially in immunocompromised patients. View related videos Next-Generation Sequencing Technology Drives Discoveries in Disease Pathology https://www.youtube.com/watch?v=vv2XR4OpM2M View related information https://www.illumina.com/areas-of-interest/microbiology/microbial-genomics-resources/webinars.html Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc For In Vitro Diagnostic Use.